Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Trivalent Influenza Vaccine (AD07030) in Healthy Adults
NCT03784885Phase 2Completed
- Sponsor
- Advagene Biopharma Co., Ltd.
- Start
- Sep 2017
- Primary completion
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AD07030 in influenza, sponsored by Advagene Biopharma Co., Ltd.. Started Sep 2017; status: completed.
02
Drugs
AD07030
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03784885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784885.